LIBTAYO

sanofi-aventis canada inc🇨🇦 Health Canada

Approval Id: 7ccf1eeabc0e02de
Drug Approval Canada Name: LIBTAYO
Product Name: LIBTAYO
Status: Cancelled Post Market
Status Date: 2023-12-08
Original Market Date: 2019-05-24
Din: 02487152
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FF06 CEMIPLIMAB
Atc Name: l 01 ff 06
Aig Number: 0161350001
Company Name: sanofi-aventis canada inc
Company Address: 1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4

CEMIPLIMAB

250 MG / 5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7ccf1eeabc0e02de

Type

Standard